President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
UF researchers have discovered a combination of two over-the-counter compounds that may significantly improve the recovery of patients infected with COVID-19. Studies in mice have been successful, with the health of test subjects improving significantly or ending in full recovery.
UF Discovery Could Lead to Earlier Pancreatic Cancer Treatments
Pancreatic cancer’s stealth-like nature has the attention of University of Florida scientists, who have discovered a way to reverse a key cellular process involved in its progression.
Scientists Hone In on Treatment for Stimulant Use Disorder
University of Florida researchers have received a $19 million grant to tackle the growing problem of stimulant use disorder.
Sparian Biosciences Awarded $19 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development
Sparian Biosciences, Inc., a clinical-stage CNS-focused biopharmaceutical company, announced it has been awarded a $19 million, five-year grant to fund the development of SBS-518 from IND submission through Phase 1 clinical development.
Newly Discovered Probiotic Could Protect Caribbean Corals Threatened by Deadly, Devastating Disease
Researchers with the Smithsonian’s National Museum of Natural History and the University of Florida have discovered the first effective bacterial probiotic for treating and preventing stony coral tissue loss disease, or SCTLD, a mysterious ailment that has devastated Florida’s coral reefs since 2014 and is rapidly spreading throughout the Caribbean.
Targeting a Human Protein To Squash SARS-CoV-2 and Other Viruses
More than two years into the COVID-19 pandemic, people are realizing that the “new normal” will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers are looking toward new strategies. In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
UF College of Pharmacy Moves Into Top 3 of National Research Rankings
The University of Florida College of Pharmacy moved up two places to No. 3 in the nation for total research funding in the latest American Association of Colleges of Pharmacy, or AACP, report released June 23. The No. 3 ranking is the highest ever achieved by the college when compared to peer institutions
Three UF Faculty Elected to Academy of Science, Engineering, and Medicine of Florida
Three University of Florida faculty will be inducted into the Academy of Science, Engineering, and Medicine of Florida in 2022. The academy, which recognizes the work of individuals of the State of Florida who have made major achievements in science, engineering, and medicine, will present awards to the following faculty during its annual meeting on November 5-6 in Orlando.
New Medicinal Plants Course Addresses Industry Needs
Emerging industries require a skilled workforce to function. Sometimes, the industry begins to boom before employers can hire a sufficient number of skilled employees. That was the case for many employers in the medicinal plant industry, which includes crops like hemp, kava and kratom. Faculty from two University of Florida colleges worked together to help meet that demand with a new course.
